Trials / Completed
CompletedNCT01328899
Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)
Feasibility Study of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of Emphysema
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter single arm open label study. The primary objective is to evaluate the safety and effectiveness of the Lung Volume Reduction Coil (LVRC) for the treatment of patients with emphysema in multiple centers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lung Volume Reduction Coil (LVRC) (PneumRx's) | Lung Volume Reduction Coil |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-04-05
- Last updated
- 2021-07-21
Locations
11 sites across 3 countries: France, Germany, Netherlands
Source: ClinicalTrials.gov record NCT01328899. Inclusion in this directory is not an endorsement.